16-1153750-G-A
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_021098.3(CACNA1H):c.13G>A(p.Ala5Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000111 in 1,212,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A5S) has been classified as Benign.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -11 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.13G>A | p.Ala5Thr | missense_variant | Exon 2 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000569107.6 | c.13G>A | p.Ala5Thr | missense_variant | Exon 2 of 34 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000711493.1 | c.13G>A | p.Ala5Thr | missense_variant | Exon 2 of 34 | ENSP00000518778.1 | ||||
CACNA1H | ENST00000565831.7 | c.13G>A | p.Ala5Thr | missense_variant | Exon 2 of 34 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000711450.1 | c.13G>A | p.Ala5Thr | missense_variant | Exon 2 of 35 | ENSP00000518762.1 | ||||
CACNA1H | ENST00000564231.6 | c.13G>A | p.Ala5Thr | missense_variant | Exon 2 of 35 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000638323.1 | c.13G>A | p.Ala5Thr | missense_variant | Exon 2 of 35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000562079.6 | c.13G>A | p.Ala5Thr | missense_variant | Exon 2 of 34 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000711438.1 | c.13G>A | p.Ala5Thr | missense_variant | Exon 2 of 34 | ENSP00000518754.1 | ||||
CACNA1H | ENST00000711482.1 | c.13G>A | p.Ala5Thr | missense_variant | Exon 2 of 36 | ENSP00000518771.1 | ||||
CACNA1H | ENST00000711485.1 | c.13G>A | p.Ala5Thr | missense_variant | Exon 2 of 35 | ENSP00000518774.1 | ||||
CACNA1H | ENST00000711455.1 | c.13G>A | p.Ala5Thr | missense_variant | Exon 2 of 36 | ENSP00000518768.1 | ||||
CACNA1H | ENST00000711483.1 | c.13G>A | p.Ala5Thr | missense_variant | Exon 2 of 35 | ENSP00000518772.1 | ||||
CACNA1H | ENST00000711456.1 | c.13G>A | p.Ala5Thr | missense_variant | Exon 2 of 34 | ENSP00000518769.1 | ||||
CACNA1H | ENST00000621827.2 | n.13G>A | non_coding_transcript_exon_variant | Exon 2 of 37 | 6 | ENSP00000518766.1 | ||||
CACNA1H | ENST00000637236.3 | n.13G>A | non_coding_transcript_exon_variant | Exon 2 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.13G>A | non_coding_transcript_exon_variant | Exon 2 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.13G>A | non_coding_transcript_exon_variant | Exon 2 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.13G>A | non_coding_transcript_exon_variant | Exon 2 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.13G>A | non_coding_transcript_exon_variant | Exon 2 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.13G>A | non_coding_transcript_exon_variant | Exon 2 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.13G>A | non_coding_transcript_exon_variant | Exon 2 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.13G>A | non_coding_transcript_exon_variant | Exon 2 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.13G>A | non_coding_transcript_exon_variant | Exon 2 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711484.1 | n.13G>A | non_coding_transcript_exon_variant | Exon 2 of 35 | ENSP00000518773.1 | |||||
CACNA1H | ENST00000711486.1 | n.13G>A | non_coding_transcript_exon_variant | Exon 2 of 37 | ENSP00000518775.1 | |||||
CACNA1H | ENST00000711487.1 | n.13G>A | non_coding_transcript_exon_variant | Exon 2 of 36 | ENSP00000518776.1 | |||||
CACNA1H | ENST00000711488.1 | n.13G>A | non_coding_transcript_exon_variant | Exon 2 of 35 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes AF: 0.000537 AC: 81AN: 150972Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 454 AF XY: 0.00
GnomAD4 exome AF: 0.0000500 AC: 53AN: 1060948Hom.: 0 Cov.: 31 AF XY: 0.0000319 AC XY: 16AN XY: 501894 show subpopulations
GnomAD4 genome AF: 0.000536 AC: 81AN: 151074Hom.: 0 Cov.: 30 AF XY: 0.000569 AC XY: 42AN XY: 73840 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.13G>A (p.A5T) alteration is located in exon 2 (coding exon 1) of the CACNA1H gene. This alteration results from a G to A substitution at nucleotide position 13, causing the alanine (A) at amino acid position 5 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at